Multiplex Assays Market by Product (Consumables, Instruments, Software & Services), Type (Nucleic Acid, Protein, Cell), Technology (Flow Cytometry, Luminescence, Application (R&D, Diagnosis), End User (Pharma & Biotech, Hospital), and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
Multiplex Assays Market Overview
The global Multiplex Assays Market size is projected to reach a CAGR of 10.3% from 2023-2030.
Multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth factors, cytokines, and chemokines) are profiled by detecting and quantifying them simultaneously. This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect more information from minute quantities of proteins or other analytes in lesser time as compared to conventional methods such as ELISA. Multiplex assays are widely used for pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, and forensic studies.
The Multiplex assays are extensively used in companion diagnostics, and in drug development. The edge of the multiplex assays over the single plex assays which include reduced reaction tie, reagents, and analyte concentration, helps to deliver the assay result faster and deal with the rare samples (low concentration samples). The massive prevalence of chronic and infectious diseases offers more opportunities for the market by creating more demand for multiplex assays. Market growth is further driven by the following factors such as the increasing adoption of companion diagnostics, the increasing incidence of chronic and infectious diseases, the growing awareness of disease diagnosis, and the need for effective analytical platforms in research and clinical diagnostics to reduce the operational costs and the time taken for diagnosis.
On the other hand, the high expenses of the equipment are posed challenges to the researcher and manufacturers to perform the multiplex assay testing at an affordable price. Also, the Quality control (QC) standards for multiplex assays are more stringent compared to single plex assays, this significantly restricts the Multiplex Assays Market
Get a Sample Copy of the Multiplex Assays Market Research Report: https://www.delvens.com/get-free-sample/multiplex-assays-market
The outbreak of COVID-19 has disrupted workflows in the healthcare sector across the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of health care. The overall impact of the COVID-19 pandemic remained positive for key players in the multiplex assay industry. As multiplex assays are been used for covid diagnosis, there has been a massive demand for a multiplex of the SARS-CoV-2 assay such as multiplex point-of-care assays is positively boosting the growth of the multiplex assay market during the pandemic. Several companies received the FDA emergency use authorization for their COVID-19 multiplex assays to meet the soaring demand for the high volume of testing.
Delvens Industry Expert's Standpoint
The desire for more effective and affordable diagnostic tests is expanding, and technical advancements that make it possible to identify more analytes in a single sample are driving the multiplex assay market's rapid growth and evolution. While there are a few big firms and many smaller businesses competing in the market, it is rather fragmented. However, there is a tendency towards consolidation as larger companies attempt to increase their product offerings and increase their market share. The market for multiplex assays is projected to keep expanding in the upcoming years due to the continued need for more efficient diagnostic tools in industries like medical diagnostics and drug development. Continuous innovation and technical development, as well as rising demand from a range of end-users, including as clinical laboratories, research institutes, and pharmaceutical firms, are projected to be the main drivers of this expansion.
Key Findings
• The product and services segment are further segmented into Consumables, Instruments, and Software and Services. The consumables segment is anticipated to hold the largest share during the forecast period. This can be attributed to the recurring purchase of assays and reagents for increasing research applications.
• The type segment is further segmented into Protein Multiplex Assays, Nucleic Acid Multiplex Assays, and Cell-Based Multiplex Assays. The protein-based multiplex assay segment is expected to account for the largest share of the global multiplex assay market. This large share can be attributed to the increasing focus on proteomics studies for biomarker research and clinical diagnostics.
• The technology segment is further segmented into Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, and Other Technologies. The flow cytometry segment is expected to account for the largest share of the global multiplex assay market. The large share can be attributed to the wide applications of flow cytometry in the detection and measurement of protein expression, RNA, and cell health status (cell viability & toxicity) alongside the characterization and identification of various cell types.
• The application segment is further segmented into Research & Development and Clinical diagnostics. the research & development segment is expected to account for the largest share of the global multiplex assays market. This large share can be attributed to the wide applications of multiplex assay technologies in research & development functions.
• The end-user segment is further segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, and Other End Users. The pharmaceutical & biotechnology companies’ segment is expected to account for the largest share of the global multiplex assays market. This large share can be attributed to the increasing adoption of multiplex assays in drug discovery and development by pharmaceuticals and the growing focus of biotechnology companies on developing biosimilars and monoclonal antibodies.
Multiplex Assays Market Regional Analysis
North America to Dominate the Market
• North America was the largest regional market in terms of revenue. The increasing prevalence of chronic diseases, such as cancer, the aging population, growing demand for targeted and personalized medicine, and favourable government initiatives are the primary factors behind the large market size. The growth can also be attributed to the presence of sophisticated diagnostics laboratories and a high acceptance rate of novel assay technologies.
• Asia Pacific is expected to register the highest CAGR in the market during the forecast period. Growth in the APAC region is largely driven by the increasing R&D investment by the government and increasing infrastructural development in the region.
Multiplex Assays Market Competitive Landscape
• Luminex Corporation
• Thermo Fisher Scientific Inc.
• Illumina Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• Becton, Dickinson, and Company
• Abcam PLC
• Seegene Inc.
• Meso Scale Diagnostics LLC
• Randox Laboratories Ltd.
• DIASORIN S.P.A.
• MERCK KGAA
• AGILENT TECHNOLOGIES, INC.
• QUANTERIX
• BIO-TECHNE
• OLINK
• SEEGENE INC.
• SIEMENS HEALTHINEERS AG
• PERKINELMER INC.
• SHIMADZU CORPORATION
• PROMEGA CORPORATION
• ENZO BIOCHEM INC.
• CAYMAN CHEMICAL
• BOSTER BIOLOGICAL TECHNOLOGY
• ANTIGENIX AMERICA, INC.
• QUANSYS BIOSCIENCES INC.
• RAYBIOTECH LIFE, INC.
Inquire before you purchase to increase your business' revenue: https://www.delvens.com/Inquire-before-buying/multiplex-assays-market
Multiplex Assays Market Recent Developments
• In February 2022, Adobe added mobile marketing personalization capabilities to journey optimizer that enables users to better engage their customers on smartphones. The seven capabilities include Message Designer, with which users can design personalized email, push notifications and in-app messages from one console for customers on mobile devices; personalized app experiences, which consider app usage and other factors; and unified customer profiles, which drive analytics in workflows.

• In December 2021, with the Dynamics 365 Marketing December 2021 update, the user can create journey branches based on any attribute, track unsubscribed users in real-time marketing insights, and manage Microsoft Teams meeting options from the Dynamics 365 Marketing app. The update also includes general performance upgrades and bug fixes.
Reasons to Acquire in the Multiplex Assays Market
• Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors.
• Gain authentic and granular data access for Multiplex Assays Market so as to understand the trends and the factors involved behind changing market situations.
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.
Direct Purchase of Multiplex Assays Market Report Research Report: https://www.delvens.com/checkout/multiplex-assays-market
Frequently Asked Questions
What are the years considered to study Multiplex Assays Market?
What is the compound annual growth rate (CAGR) of the Multiplex Assays Market?
Which region holds the largest market share in Multiplex Assays Market?
Which region is the fastest growing region in Multiplex Assays Market?
Who are the major players in Multiplex Assays Market?
Browse Related Reports:
Hearing Aids Market – Trends Forecast Till 2030
Hearing Aids Market, By Product Type (BTE, Canal Hearing Aids), By Technology (Digital, Analog), By Sales Channel (E-commerce, Retail Sales), and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
Mapping Catheters Market – Trends Forecast Till 2030
Mapping Catheters Market, by Product (Contact Mapping Systems, Non-Contact Mapping Systems), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT), End User (Hospitals, Clinics, Others) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
ELISpot and FluoroSpot Assay Market – Trends Forecast Till 2030
The ELISpot and FluoroSpot Assay Market is Segmented By Product (Analyzers, Assay Kits, and Ancillary Products), Application (Research and Diagnostics), End-User (Hospitals & Clinical Labs, Biopharmaceutical Companies, and Research Institutes) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact Us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-8638-5055
[email protected]